title: Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation.
abstract: Cell wall thickening is a common feature among daptomycin-resistant Staphylococcus aureus strains. However, the mechanism(s) leading to this phenotype is unknown. We examined a number of cell wall synthesis pathway parameters in an isogenic strain set of S. aureus bloodstream isolates obtained from a patient with recalcitrant endocarditis who failed daptomycin therapy, including the initial daptomycin-susceptible parental strain (strain 616) and two daptomycin-resistant strains (strains 701 and 703) isolated during daptomycin therapy. Transmission electron microscopy demonstrated significantly thicker cell walls in the daptomycin-resistant strains than in the daptomycin-susceptible strain, a finding which was compatible with significant differences in dry cell weight of strain 616 versus strains 701 to 703 (P < 0.05). Results of detailed analysis of cell wall muropeptide composition, the degree of peptide side chain cross-linkage, and the amount of the peptidoglycan precursor, UDP-MurNAc-pentapeptide, were similar in the daptomycin-susceptible and daptomycin-resistant isolates. In contrast, the daptomycin-resistant strains contained less O-acetylated peptidoglycan. Importantly, both daptomycin-resistant strains synthesized significantly more wall teichoic acid (WTA) than the parental strain (P < 0.001). Moreover, the proportion of D-alanylated WTA species was substantially higher in the daptomycin-resistant strains than in the daptomycin-susceptible parental strain (P < 0.05 in comparing strain 616 versus strain 701). The latter phenotypic findings correlated with (i) enhanced tagA and dltA gene expression, respectively, and (ii) an increase in surface positive charge observed in the daptomycin-resistant versus daptomycin-susceptible isolates. Collectively, these data suggest that increases in WTA synthesis and the degree of its D-alanylation may play a major role in the daptomycin-resistant phenotype in some S. aureus strains.
authors: Interfacultary Institute of Microbiology and Infection Medicine, Microbial Genetics, University of Tübingen, Auf der Morgenstelle 28, 72076 Tübingen, Germany.
authors: Ute
authors: U
authors: Bertsche
authors: Christopher
authors: C
authors: Weidenmaier
authors: Daniel
authors: D
authors: Kuehner
authors: Soo-Jin
authors: SJ
authors: Yang
authors: Stefanie
authors: S
authors: Baur
authors: Stefanie
authors: S
authors: Wanner
authors: Patrice
authors: P
authors: Francois
authors: Jacques
authors: J
authors: Schrenzel
authors: Michael R
authors: MR
authors: Yeaman
authors: Arnold S
authors: AS
authors: Bayer
references: J Bacteriol. 1997 Jan;179(1):9-16
references: 8981974
references: Antimicrob Agents Chemother. 2010 Aug;54(8):3079-85
references: 20498310
references: Am J Health Syst Pharm. 2005 Jun 1;62(11):1145-58
references: 15914875
references: Antimicrob Agents Chemother. 2006 Mar;50(3):1079-82
references: 16495273
references: Clin Infect Dis. 2007 Sep 1;45(5):601-8
references: 17682996
references: J Clin Microbiol. 2006 Feb;44(2):655-6
references: 16455939
references: J Biol Chem. 1999 Mar 26;274(13):8405-10
references: 10085071
references: J Infect Dis. 2010 May 1;201(9):1414-21
references: 20307206
references: J Clin Microbiol. 2008 Jan;46(1):220-4
references: 18003803
references: Antimicrob Agents Chemother. 2009 Apr;53(4):1610-8
references: 19164139
references: J Biol Chem. 1992 Jun 5;267(16):11248-54
references: 1597460
references: Microb Drug Resist. 1996 Summer;2(2):201-7
references: 9158760
references: J Bacteriol. 2005 Sep;187(17):5893-900
references: 16109930
references: Anal Biochem. 1975 Aug;67(2):503-6
references: 1163770
references: Antimicrob Agents Chemother. 2008 Dec;52(12):4289-99
references: 18824611
references: Antimicrob Agents Chemother. 2007 Sep;51(9):3445-8
references: 17620372
references: J Antimicrob Chemother. 2011 Aug;66(8):1696-711
references: 21622973
references: PLoS One. 2010 Oct 07;5(10):e13227
references: 20949105
references: Mol Microbiol. 2004 Jul;53(2):675-85
references: 15228543
references: Antimicrob Agents Chemother. 2008 Mar;52(3):980-90
references: 18086846
references: J Biol Chem. 2000 Apr 7;275(14):9910-8
references: 10744664
references: Biochim Biophys Acta. 2006 Sep;1758(9):1215-23
references: 16615993
references: Antimicrob Agents Chemother. 2009 Jun;53(6):2636-7
references: 19289517
references: Antimicrob Agents Chemother. 2008 Jan;52(1):269-78
references: 17954690
references: Chem Biol. 2008 Feb;15(2):95-6
references: 18291312
references: J Infect Dis. 2003 Mar 15;187(6):929-38
references: 12660939
references: FEMS Microbiol Lett. 1991 Mar 1;62(2-3):253-7
references: 1904044
references: J Bacteriol. 2005 Oct;187(19):6719-25
references: 16166534
references: Antimicrob Agents Chemother. 2009 Jun;53(6):2312-8
references: 19332678
references: J Clin Microbiol. 2005 Oct;43(10):5285-7
references: 16207998
references: Infect Immun. 2007 Apr;75(4):2084-7
references: 17261607
references: Mol Microbiol. 2005 Feb;55(3):778-87
references: 15661003
references: Nat Rev Microbiol. 2008 Apr;6(4):276-87
references: 18327271
references: J Bacteriol. 2006 Jun;188(12):4183-9
references: 16740924
references: J Infect Dis. 2005 May 15;191(10):1771-7
references: 15838806
references: Antimicrob Agents Chemother. 2006 Dec;50(12):4195-7
references: 17043121
references: Antimicrob Agents Chemother. 2003 Aug;47(8):2538-44
references: 12878516
references: J Infect Dis. 2009 Dec 15;200(12):1916-20
references: 19919306
references: Nat Med. 2004 Mar;10(3):243-5
references: 14758355